Invention Grant
- Patent Title: Thromboxane receptor antagonists in AERD/asthma
-
Application No.: US16687151Application Date: 2019-11-18
-
Publication No.: US11571412B2Publication Date: 2023-02-07
- Inventor: Leo Pavliv
- Applicant: Cumberland Pharmaceuticals Inc.
- Applicant Address: US TN Nashville
- Assignee: Cumberland Pharmaceuticals Inc.
- Current Assignee: Cumberland Pharmaceuticals Inc.
- Current Assignee Address: US TN Nashville
- Agency: Vivicar Law, PLLC
- Main IPC: A61K31/422
- IPC: A61K31/422 ; A61P11/00 ; A61P11/06 ; A61K31/616
Abstract:
The present invention is directed to methods of treating AERD (aspirin exacerbated respiratory disease) and/or asthma via the administration of a thromboxane receptor antagonist to a patient in need thereof.
Public/Granted literature
- US20200155513A1 Thromboxane Receptor Antagonists in AERD/Asthma Public/Granted day:2020-05-21
Information query
IPC分类:
